Prior work in hepatocellular carcinoma (HCC) demonstrated that CCT4 physically interacts with Cdc20, a key activator of APC/C, and this interaction promotes the disassembly of the mitotic checkpoint complex (MCC) to activate APC/C (39). Here, CDC20 is linked to hepatocellular carcinoma.